14. Comparison 9. Bromocriptine versus placebo: global functioning.

Study	Outcome (instrument)	Experimental groupa (n = 9)		Control groupa (n = 9)		Statisticb
		Mean scores at baseline	Mean scores at endpoint	Mean scores at baseline	Mean scores at endpoint
Powell 1995	Global functioning (GAS‐high)c	55.8	76.0	57.9	75.7	Favours neither condition
Powell 1995	Global functioning (GAS‐low)c	36.0	47.4	34.8	43.0	Favours neither condition
Powell 1995	Global functioning (SCL‐90 GSI subscale)d	0.8	0.4	0.8	0.7	Favours neither condition
GAS: Global Assessment Scale; GSI: Global Severity Index; SCL‐90: Symptom Check List‐90

^aStandard deviations not reported
^bTrend‐over‐time analyses based on measurements at baseline and six months, with additional measurements at 2, 4, and 6 weeks, and then at 2, 3, 4, and 5 months; analyses conducted by trial investigators
^cHigh scores indicate better functioning
^dHigh scores indicate greater severity